Remix Therapeutics™ Appoints Dominic Reynolds, Ph.D., as Chief Scientific Officer Portfolio News / Karina Tin February 1, 2024 Remix Therapeutics™ Appoints Dominic Reynolds, Ph.D., as Chief Scientific Officer Read More »
